Turchin Alexander, Shubina Maria, Breydo Eugene, Pendergrass Merri L, Einbinder Jonathan S
Clinical Informatics Research and Development, Suite 201, 93 Worcester St, Wellesley, MA 02481, USA.
J Am Med Inform Assoc. 2009 May-Jun;16(3):362-70. doi: 10.1197/jamia.M2777. Epub 2009 Mar 4.
OBJECTIVE To compare information obtained from narrative and structured electronic sources using anti-hypertensive medication intensification as an example clinical issue of interest. DESIGN A retrospective cohort study of 5,634 hypertensive patients with diabetes from 2000 to 2005. MEASUREMENTS The authors determined the fraction of medication intensification events documented in both narrative and structured data in the electronic medical record. The authors analyzed the relationship between provider characteristics and concordance between intensifications in narrative and structured data. As there is no gold standard data source for medication information, the authors clinically validated medication intensification information by assessing the relationship between documented medication intensification and the patients' blood pressure in univariate and multivariate models. RESULTS Overall, 5,627 (30.9%) of 18,185 medication intensification events were documented in both sources. For a medication intensification event documented in narrative notes the probability of a concordant entry in structured records increased by 11% for each study year (p < 0.0001) and decreased by 19% for each decade of provider age (p = 0.035). In a multivariate model that adjusted for patient demographics and intraphysician correlations, an increase of one medication intensification per month documented in either narrative or structured data were associated with a 5-8 mm Hg monthly decrease in systolic and 1.5-4 mm Hg decrease in diastolic blood pressure (p < 0.0001 for all). CONCLUSION Narrative and structured electronic data sources provide complementary information on anti-hypertensive medication intensification. Clinical validity of information in both sources was demonstrated by correlation with changes in blood pressure.
目的 以抗高血压药物强化治疗作为一个具有临床研究意义的实例,比较从叙述性和结构化电子数据源获取的信息。设计 一项对2000年至2005年期间5634例糖尿病高血压患者的回顾性队列研究。测量 作者确定了电子病历中叙述性和结构化数据中记录的药物强化治疗事件的比例。作者分析了医疗服务提供者特征与叙述性和结构化数据中强化治疗一致性之间的关系。由于没有药物信息的金标准数据源,作者通过在单变量和多变量模型中评估记录的药物强化治疗与患者血压之间的关系,对药物强化治疗信息进行了临床验证。结果 总体而言,18185例药物强化治疗事件中有5627例(30.9%)在两种数据源中均有记录。对于叙述性记录中记录的药物强化治疗事件,结构化记录中出现一致记录的概率每增加一个研究年份就增加11%(p<0.0001),而提供者年龄每增加一个十年则降低19%(p = 0.035)。在一个对患者人口统计学和医生内部相关性进行调整的多变量模型中,叙述性或结构化数据中每月记录的药物强化治疗增加一次,与收缩压每月降低5 - 8 mmHg和舒张压降低1.5 - 4 mmHg相关(所有p<0.0001)。结论 叙述性和结构化电子数据源提供了关于抗高血压药物强化治疗的补充信息。两种数据源中信息的临床有效性通过与血压变化的相关性得到了证实。